Alnylam Pharmaceuticals, Inc. (MM) Stock Price - ALNY

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 128.50 ▲ 0.99 (0.78%)
Company Name Stock Ticker Symbol Market Type ISIN
Alnylam Pharmaceuticals, Inc. (MM) ALNY NASDAQ Common Stock US02043Q1076
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +1.13 +0.89% 127.51 128.59 125.57 126.17 126.38 20:00:00
Bid Price Ask Price Spread Spread % News
123 150 27 18.00% 1 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,411 901,011 $ 126.9847 $ 114.41M 1.38M 35.98 - 147.63
Last Trade Time Type Quantity Stock Price Currency
16:35:04 formt 2,898 $128.50 USD

Alnylam Pharmaceuticals, Inc. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 11.82B 92.73M $ -410.11M -4.79 0.00 40.8M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.00 0.00% 11.84k 94.40%

more financials information »

Alnylam Pharmaceuticals, Inc. (MM) News

Date Time Source News Article
11/17/201717:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
11/17/201707:50GlobeNewswire Inc.New Research: Key Drivers of Growth for Great Plains Energy,..
11/16/201716:00Business WireAlnylam Pharmaceuticals Announces Closing of Public Offering..
11/16/201713:40GlobeNewswire Inc.Arbutus’ LNP Licensee Alnylam Initiates Rolling Submission..
11/16/201707:00Business WireAlnylam Initiates Rolling Submission of New Drug Application..
11/14/201717:10Edgar (US Regulatory)Current Report Filing (8-k)
11/14/201717:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

Latest ALNY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALNY Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week137.6140.795124.61130.06931M3M2M-10.09-7.33%
1 Month115.61147.63111.25127.5601776k4M1M11.910.29%
3 Months84.49147.6370.76111.8789424k18M2M43.0250.92%
6 Months71.54147.6362.9698.1423376k18M1M55.9778.24%
1 Year46.5147.6335.9876.5766236k18M1M81.01174.22%
3 Years91.31147.6331.3877.9195018M937k36.239.65%
5 Years16.5147.6315.5671.1688018M827k111.01672.79%

Alnylam Pharmaceuticals, Inc. (MM) Description

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20171119 02:56:17